NCT06126822: Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC
- State
- Under way
- Phase
- Phase 3
- People
- 624 planned
- Started
- 25 Feb 2025
- Primary completion
- Oct 2026
- Arms
- Zabdeno/Mvabea® vaccinated - Zabdeno® booster, Ervebo® vaccinated - Zabdeno® booster
- Results
- None posted
- 13 Nov 2023: Trial registered
- 25 Feb 2025: Trial started